SEPTEMBER 2024: 

Loma presents at Nordic Life Science Days 2024. 

Loma participated in Nordic Life Science (NLS) Days 2024, where we had the opportunity to present our pioneering work on developing a therapeutic vaccine against HPV+ cancers. Engaging with life science leaders, investors, and innovators from across the globe, we shared our vision for transforming cancer treatment and connected with key stakeholders in the industry. 

NLS Days provided a dynamic platform for us to present our latest advancements and discuss our mission to make a lasting impact on HPV-related cancers. This experience allowed us to connect with potential partners, gain valuable insights from industry experts, and discuss collaboration opportunities that can help bring our innovative therapeutic vaccine closer to patients. 

Our participation at NLS Days has strengthened our resolve and network, equipping us with fresh perspectives and valuable feedback to fuel the next stages of our development. We are grateful for the opportunity to be part of this influential event and to join the conversation around innovation in life sciences. 

Thank you to NLS Days for hosting such an inspiring event and stay tuned as we continue on our path to make a meaningful impact in cancer care.